Lan Chen
Lan Chen has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Chunlin Chen
Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou, China
2 shared publications - Ping Liu
Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou, China
2 shared publications Andrew Albright
Merck & Co., Inc., Kenilworth, USA
1 shared publicationCheng Peng
Department of Obstetrics and Gynaecology, Nanfang Hospital, Southern Medical University, Guangzhou, China
1 shared publication- David C. Nickle
Affiliations UW School of Global Health, Seattle, Washington, United States of America, Monoceros Biosystems, San Diego, California, United States of America
1 shared publication - Donglin Li
College of Biology and Agriculture, Shaoguan University, Shaoguan, Guangdong, China
1 shared publication
Latest Publications
- Open Access
- 22 March 2021
- Published by Springer Nature in Infectious Diseases and Therapy
- Vol. 10 (2) , 853-870
Global Landscape of Clostridioides Difficile Phylogeography, Antibiotic Susceptibility, and Toxin Polymorphisms by Post-Hoc Whole-Genome Sequencing from the MODIFY I/II Studies
Introduction Clostridioides (Clostridium) difficile infection, the leading cause of healthcare-associated diarrhea, represents a significant burden on global healthcare systems. Despite being a global issue, information on C. difficile from a global perspective is lacking. The aim of this study is to model the global phylogeography of clinical C. difficile. Methods Using samples collected from the MODIFY I and II studies (NCT01241552, NCT01513239), we performed whole-genome sequencing of 1501 clinical isolates including 37 novel sequence types (STs), representing the largest worldwide collection to date. Results Our data showed ribotypes, multi-locus sequence typing clades, and whole-genome phylogeny were in good accordance. The clinical C. difficile genome was found to be more conserved than previously reported (61% core genes), and modest recombination rates of 1.4–5.0 were observed across clades. We observed a significant continent distribution preference among five C. difficile clades (Benjamini-Hochberg corrected Fisher’s exact test P < 0.01); moreover, weak association between geographic and genetic distance among ribotypes suggested sources beyond healthcare-related transmission. Markedly different trends of antibiotic susceptibility among lineages and regions were identified, and three novel mutations (in pyridoxamine 5′-phosphate oxidase family protein: Tyr130Ser, Tyr130Cys, and a promoter SNP) associated with metronidazole-reduced susceptibility were discovered on a nim-related gene and its promotor by genome-wide association study. Toxin gene polymorphisms were shown to vary within and between prevalent ribotypes, and novel severe mutations were found on the tcdC toxin regulator protein. Conclusion Our systematic characterization of a global set of clinical trial C. difficile isolates from infected individuals demonstrated the complexity of the genetic makeup of this pathogenic organism. The geographic variability of clades, variability in toxin genes, and mutations associated with antibiotic susceptibility indicate a highly complex interaction of C. difficile between host and environment. This dataset will provide a useful resource for validation of findings and future research of C. difficile.
- 22 March 2021
- Published by Springer Nature in Infectious Diseases and Therapy
- Vol. 10 (2) , 853-870
Open AccessGlobal Landscape of Clostridioides Difficile Phylogeography, Antibiotic Susceptibility, and Toxin Polymorphisms by Post-Hoc Whole-Genome Sequencing from the MODIFY I/II Studies
Introduction Clostridioides (Clostridium) difficile infection, the leading cause of healthcare-associated diarrhea, represents a significant burden on global healthcare systems. Despite being a global issue, information on C. difficile from a global perspective is lacking. The aim of this study is to model the global phylogeography of clinical C. difficile. Methods Using samples collected from the MODIFY I and II studies (NCT01241552, NCT01513239), we performed whole-genome sequencing of 1501 clinical isolates including 37 novel sequence types (STs), representing the largest worldwide collection to date. Results Our data showed ribotypes, multi-locus sequence typing clades, and whole-genome phylogeny were in good accordance. The clinical C. difficile genome was found to be more conserved than previously reported (61% core genes), and modest recombination rates of 1.4–5.0 were observed across clades. We observed a significant continent distribution preference among five C. difficile clades (Benjamini-Hochberg corrected Fisher’s exact test P < 0.01); moreover, weak association between geographic and genetic distance among ribotypes suggested sources beyond healthcare-related transmission. Markedly different trends of antibiotic susceptibility among lineages and regions were identified, and three novel mutations (in pyridoxamine 5′-phosphate oxidase family protein: Tyr130Ser, Tyr130Cys, and a promoter SNP) associated with metronidazole-reduced susceptibility were discovered on a nim-related gene and its promotor by genome-wide association study. Toxin gene polymorphisms were shown to vary within and between prevalent ribotypes, and novel severe mutations were found on the tcdC toxin regulator protein. Conclusion Our systematic characterization of a global set of clinical trial C. difficile isolates from infected individuals demonstrated the complexity of the genetic makeup of this pathogenic organism. The geographic variability of clades, variability in toxin genes, and mutations associated with antibiotic susceptibility indicate a highly complex interaction of C. difficile between host and environment. This dataset will provide a useful resource for validation of findings and future research of C. difficile.
- Open Access
- 1 January 2021
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 32 (2)
Comparison between laparoscopic and abdominal radical hysterectomy for stage IB1 and tumor size <2 cm cervical cancer with visible or invisible tumors: a multicentre retrospective study
Li P, et al. J Gynecol Oncol. 2020 Oct;32:e17. https://doi.org/10.3802/jgo.2021.32.e17
- 1 January 2021
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 32 (2)
Open AccessComparison between laparoscopic and abdominal radical hysterectomy for stage IB1 and tumor size <2 cm cervical cancer with visible or invisible tumors: a multicentre retrospective study
Li P, et al. J Gynecol Oncol. 2020 Oct;32:e17. https://doi.org/10.3802/jgo.2021.32.e17
- 1 January 2019
- Published by Elsevier in European Journal of Radiology
- Vol. 110, 242-248
A modified model can improve the accuracy of foetal weight estimation by magnetic resonance imaging
- 1 January 2019
- Published by Elsevier in European Journal of Radiology
- Vol. 110, 242-248
A modified model can improve the accuracy of foetal weight estimation by magnetic resonance imaging